Virtual Library

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

Filter Results:

Show Only Available Presentations

  • +

    P1.06 - Poster Session 1 - Prognostic and Predictive Biomarkers

    • Type: Poster Session
    • Track: Biology
    • Presentations: 59
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.06-040 - The Bim Deletion Polymorphism profile and its relationship with TKIs Resistance in Chinese NSCLC Population

      09:30 - 09:30  |  Author(s): Y. Zhang

      • Abstract

      Loading...

  • +

    P1.22 - Poster Session 1 - Epidemiology, Etiology

    • Type: Poster Session
    • Track: Prevention & Epidemiology
    • Presentations: 12
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.22-001 - An Nickel Workers Cohort Study in China (Jinchuan Cohort)-the Largest Nickel Population in World

      09:30 - 09:30  |  Author(s): Y. Bai

      • Abstract

      Loading...

  • +

    P2.02 - Poster Session 2 - Novel Cancer Genes and Pathways

    • Type: Poster Session
    • Track: Biology
    • Presentations: 21
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.02-021 - Implications of CXCR4 and Estrogen/Progesterone Receptor (ER/PR) pathway activity in Non Small Cell Lung Cancer (NSCLC)

      15:10 - 15:27  |  Author(s): S. Withecomb

      • Abstract

      Loading...

  • +

    P2.03 - Poster Session 2 - Technology and Novel Development

    • Type: Poster Session
    • Track: Biology
    • Presentations: 7
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.03-001 - Gene Expression Profile of A549 Cells from Tissue of 4D Model Predicts Poor Prognosis in Lung Cancer Patients

      09:30 - 09:30  |  Author(s): D.K. Mishra

      • Abstract

      Loading...

    • +

      P2.03-002 - Circulating Tumor Cells from 4D Model Mimic Metastatic Pattern in vivo and Gene Expression Profile Predicts Poor Prognosis in Lung Cancer Patients

      09:30 - 09:30  |  Author(s): D.K. Mishra

      • Abstract

      Loading...

  • +

    P2.07 - Poster Session 2 - Surgery

    • Type: Poster Session
    • Track: Surgery
    • Presentations: 49
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.07-033 - A comparative study of complete video-assisted thoracoscopic lobectomy and video-assisted mini-thoracotomy in treatment of lung cancer

      09:30 - 09:30  |  Author(s): Y. Zhang

      • Abstract

      Loading...

  • +

    P2.11 - Poster Session 2 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 46
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.11-007 - Relevance Between CEA Level and EGFR Mutation, Efficacy Of EGFR-TKI In Patients With Lung Adenocarcinoma

      09:30 - 09:30  |  Author(s): W.Y. Zhang

      • Abstract

      Loading...

  • +

    P2.12 - Poster Session 2 - NSCLC Early Stage

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 23
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.12-001 - Erlotinib as neoadjuvant treatment in patients with stage IIIA-N2 non-small cell lung cancer (NSCLC) with activating Epidermal Growth Factor Receptor (EGFR) mutation (NCT01217619, EASTERN): study update

      09:30 - 09:30  |  Author(s): B. Han

      • Abstract

      Loading...

  • +

    MO12 - Prognostic and Predictive Biomarkers III

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 12
    • Moderators:B. Han
    • Coordinates: 10/29/2013, 10:30 - 12:00, Parkside Ballroom B, Level 1
    • +

      MO12.03 - Biomarker analysis of a randomized, controlled, multicenter clinical trial comparing pemetrexed/cisplatin and gmcitabine/cisplatin as first-line treatment for advanced nonsquamous non-small cell lung cancer

      10:40 - 10:45  |  Author(s): L. Zhang

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MO12.05 - A new biomarker Heat shock protein 90 alpha as therapeutic monitor and predictor for lung cancer patients

      10:50 - 10:55  |  Author(s): Y. Shi

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    O18 - Cancer Control and Epidemiology II

    • Type: Oral Abstract Session
    • Track: Prevention & Epidemiology
    • Presentations: 8
    • Moderators:M.R. Spitz
    • Coordinates: 10/29/2013, 10:30 - 12:00, Bayside 103, Level 1
    • +

      O18.07 - A Retrospective Cohort Mortality Study in Jingchuan of china - the Largest Nickel Population in World

      11:35 - 11:45  |  Author(s): N. Cheng

      • Abstract

      Loading...

  • +

    O21 - SCLC II

    • Type: Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 8
    • Moderators:M. Ahn
    • Coordinates: 10/29/2013, 16:15 - 17:45, Parkside Ballroom B, Level 1
    • +

      O21.05 - A multicenter, double-blind, placebo-controlled, randomized phase 2 study of ganitumab or rilotumumab with platinum-based chemotherapy as first-line treatment for extensive-stage small-cell lung cancer (SCLC)

      17:00 - 17:10  |  Author(s): B. Glisson

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.